IRCT20200420047139N1
Completed
Phase 2
Evaluation of treatment outcome of induction chemotherapy and then Neoadjuvant chemoradiotherapy and surgery in locally advanced rectal cancer
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Enrollment
- 30
- Status
- Completed
- Last Updated
- 5 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •rectal cancer lower than 15 cm anal verge
- •T3 or T4 or N\+
- •2 \= performance status
- •liver function test upper limit normal
- •bilirubin lower than 3rd upper limit normal
- •more than 18 years , less thean 65 years
Exclusion Criteria
- •pathology except adenocarcinoma
- •metastatic disease
- •history of malignancy
- •history of chemotherapy or radiation therapy
- •pregnancy and breast feeding
- •recurrent rectal cancer
- •medical disease
- •forrbidden chemotherapy or radiation therapy
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 3
Comparative Study of Treatment Outcome in the Patients suffering from Locally Advanced Esophageal Cancers without any distant metastasis, treated with either Chemotherapy followed by Radiotherapy or Chemotherapy and Radiotherapy Simultaneously.Health Condition 1: null- Locally Advanced Squamous Cell Carcinoma Of Oesophagus.CTRI/2018/05/013773IPGMER Fluid Research Fund40
Completed
Phase 2
The phase II study of induction chemotherapy with cetuximab/S-1/low dose cisplatin for oral squamous cell carcinoma patientsoral squamous cell carcinomaJPRN-UMIN000014632The workshop of chemotherapy for oral cancer55
Active, not recruiting
Phase 1
Phase I/II study of Induction Chemotherapy with weekly RAD001, Carboplatine and Paclitaxel in Unresectable or Inoperable Locally Advanced Head and NeckSquamous Cell Carcinoma (HNSCC) - CAPRAnresectable or Inoperable locally advanced head and neck squamous cellcarcinoma without any prior chemotherapy or radiotherapyMedDRA version: 9.1Level: PTClassification code 10041823Term: Squamous cell carcinomaEUCTR2008-005702-39-FRGERCOR50
Completed
Phase 1
Phase I/II study of induction chemotherapy with docetaxel,cisplatin and fluorouracil (DCF) followed by chemoradiotherapy in patients with unresectable locally advanced esophageal carcinoma.esophageal neoplasmJPRN-UMIN000003370ational Cancer Center Hospital East30
Not yet recruiting
Not Applicable
Children with ALL: Toxicity and Quality of Life Outcomes during Induction ChemotherapyHealth Condition 1: C910- Acute lymphoblastic leukemia [ALL]CTRI/2023/08/055970Dr Antara Sanyal